Kewaunee Scientific FY27 Q1 net earnings drop 44.85% to $1.71 million; net sales fall 6.7% to $66.32 million
K
KEQU• CEO comments on pipeline and timing
- CEO Thomas D. Hull III cited strong quoting activity, though award and release timelines remain extended amid geopolitical and economic uncertainty.
Backlog and debt move in opposite directions
- Order backlog edged up to USD 169 million from USD 165.9 million since April 30; long-term debt excluding sale-leaseback fell to USD 13.8 million.
Kewaunee Scientific reports lower Q1 FY2027 earnings and sales
- Kewaunee Scientific posted Q1 FY2027 net earnings attributable to shareholders of USD 1.71 million, down 44.85% year over year.
- Net sales fell 6.7% to USD 66.32 million; diluted EPS slid to USD 0.58 from USD 1.04.
- EBITDA dropped to USD 4.53 million from USD 6.32 million; pre-tax profit declined 34.7% to USD 2.56 million.
•
Kewaunee Scientific FY27 Q1 net earnings drop 44.85% to $1.71 million; net sales fall 6.7% to $66.32 million - KEQU News | Rallies
